Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 80.64
-0.81 (-0.99%)
At close: May 8, 2026
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 18.08 billion as of May 11, 2026. Its market cap has decreased by -10.95% in one year.
Market Cap
18.08B
Enterprise Value
21.32B
Revenue
13.84B
Ranking
n/a
PE Ratio
16.49
Stock Price
80.64
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 18.08B, an increase of 153.06%. That is a compound annual growth rate of 21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 18.08B | -6.45% |
| Dec 31, 2025 | 19.33B | 24.21% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 116.13B |
| Abbott Laboratories (Pakistan) | 87.29B |
| The Searle Company | 54.95B |
| AGP Limited | 52.47B |
| Highnoon Laboratories | 51.82B |
| Ferozsons Laboratories | 17.43B |
| Macter International | 12.73B |
| Otsuka Pakistan | 3.60B |